Graham Capital Management, L.P. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$93,285
+218.9%
30,092
+43.0%
0.00%
+200.0%
Q1 2023$29,253
-97.3%
21,046
-96.1%
0.00%
-96.9%
Q4 2022$1,064,309
+146.9%
534,829
+416.6%
0.03%
+113.3%
Q1 2022$431,000103,5320.02%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders